GlassScriptPhysician profile
Freda Yin
NPI 1013558972
$649.48
in general payments reported to CMS, 2019-2025
8 companies · $47.17 in 2025
The $47.17 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $75.71 · 2023: $386 · 2024: $140 · 2025: $47.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $574.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $573.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $166.98 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Convatec INC. | $129.00 | 2023 | |
| Depuy Synthes Sales INC. | $123.33 | 2024 | Na |
| Novo Nordisk INC | $75.71 | 2022 | |
| Integra Lifesciences Corporation | $66.75 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Bioventus LLC | $40.54 | 2023-2024 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Stryker Corporation | $31.88 | 2025 | T2 |
| Globus Medical, INC. | $15.29 | 2025 | Precice® Intramedullary Limb Lengthening System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Freda Yin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.